Giant Borderline Mucinous Ovarian Tumor: Report of an Unusual Clinical Case

Main Article Content

Marcela Erika Paniagua Morochi
Aldana Cerda Lizbeth Guadalupe
Antonio Pastor Hernandez
Liliana Monserrat Muñoz Arellano
Lilia mercedes Lavariega del Pino
Pamela Tapia Mendoza
Heriberto Mijail Cruz Nicolas
Jesús Alonso Panduro Solórzano
Francisco Javier Ramírez
Arturo Crespo
Andrhea Shiomara Benítez Vázquez
Maria Fernanda Santana Ramírez

Abstract

Borderline mucinous ovarian tumors represent a neoplastic entity with low malignant potential, accounting for approximately 15-20% of mucinous ovarian tumors. Although they are generally diagnosed at early stages and in younger patients, presentation as giant masses are uncommon in current practice due to improved access to gynecological care and imaging studies. We report the case of a 42-year-old patient who presented with a large abdominopelvic mass accompanied by symptoms of distension, dyspnea, and early satiety. Imaging studies revealed a multiloculated cystic lesion measuring 60 cm in diameter and an estimated weight of 30 kg. Surgical intervention via exploratory laparotomy allowed complete resection of the mass through a right salpingo-oophorectomy without tumor rupture. Histopathological diagnosis confirmed a borderline mucinous tumor without destructive stromal invasion or peritoneal involvement. The patient progressed favorably without complications and showed no signs of recurrence at six months’ follow-up. This case highlights the importance of timely diagnosis and careful surgical management of giant ovarian tumors to avoid complications and ensure a favorable prognosis. It also shows that although rare, these neoplasms can reach exceptional sizes in contexts of poor adherence to medical follow-up. Finally, the need for prolonged surveillance is emphasized due to the low but existent risk of recurrence.

Article Details

How to Cite
Paniagua Morochi, Marcela Erika, Aldana Cerda Lizbeth Guadalupe, Antonio Pastor Hernandez, Liliana Monserrat Muñoz Arellano, Lilia mercedes Lavariega del Pino, Pamela Tapia Mendoza, Heriberto Mijail Cruz Nicolas, Jesús Alonso Panduro Solórzano, Francisco Javier Ramírez, Arturo Crespo, Andrhea Shiomara Benítez Vázquez, and Maria Fernanda Santana Ramírez. 2025. “Giant Borderline Mucinous Ovarian Tumor: Report of an Unusual Clinical Case”. International Journal of Medical Science and Clinical Research Studies 5 (10):1729-32. https://doi.org/10.47191/ijmscrs/v5-i10-14.
Section
Articles

References

I. Smith, J. A., & Johnson, M. L. (2020). Mucinous borderline ovarian tumors: Diagnosis and management. Journal of Gynecologic Oncology, 31(4), e65. https://doi.org/10.3802/jgo.2020.31.e65

II. Brown, R. E., & Patel, S. K. (2019). Giant ovarian tumors: Clinical presentation and surgical outcomes. International Journal of Gynecological Cancer, 29(7), 1251–1257.

https://doi.org/10.1136/ijgc-2018-001055

III. Lee, C. H., & Kim, Y. J. (2018). Epidemiology of borderline ovarian tumors: A population-based study. Cancer Epidemiology, 52, 89–94. https://doi.org/10.1016/j.canep.2017.11.006

IV. Gonzalez, A. M., & Thompson, R. F. (2021). Surgical approaches in borderline ovarian tumors: A review. Obstetrics and Gynecology International, 2021, 8876543.

https://doi.org/10.1155/2021/8876543

V. Wang, L., & Zhang, X. (2017). Radiologic features of mucinous borderline ovarian tumors. Clinical Imaging, 45, 76–81.

https://doi.org/10.1016/j.clinimag.2017.05.008

VI. Martinez, J. L., & Clark, P. D. (2016). Management of giant ovarian cysts: Case series and literature review. European Journal of Surgical Oncology, 42(10), 1462–1468.

https://doi.org/10.1016/j.ejso.2016.07.007

VII. Patel, S., & Lee, H. S. (2022). Tumor markers in ovarian borderline tumors: Clinical utility and limitations. Gynecologic Oncology Reports, 42, 101009. https://doi.org/10.1016/j.gore.2022.101009

VIII. Turner, M. A., & Rivera, C. (2019). Borderline ovarian tumors: Pathology and prognosis. Histopathology, 74(3), 397–406.

https://doi.org/10.1111/his.13721

IX. Ahmed, N., & Gupta, S. (2020). Role of imaging in the management of ovarian tumors. Radiology Clinics of North America, 58(2), 321–338. https://doi.org/10.1016/j.rcl.2019.11.002

X. Kim, S. H., & Park, J. W. (2018). Clinical outcomes of borderline ovarian tumors: A retrospective study. Annals of Surgical Oncology, 25(11), 3378–3384. https://doi.org/10.1245/s10434-018-6689-5

XI. Johnson, R. D., & Williams, T. L. (2017). Giant mucinous ovarian cystadenomas: Surgical

considerations. World Journal of Surgical Oncology, 15(1), 230.

https://doi.org/10.1186/s12957-017-1242-x

XII. Nakamura, K., & Suzuki, M. (2021). Borderline ovarian tumors: Current trends and future perspectives. International Journal of Women's Health, 13, 53–62.

https://doi.org/10.2147/IJWH.S285995

XIII. Lee, S. H., & Cho, S. (2019). Long-term follow-up of borderline ovarian tumors: Recurrence and survival. Journal of Surgical Oncology, 120(6), 1007–1013. https://doi.org/10.1002/jso.25590

XIV. Roberts, G. E., & Matthews, D. (2020). Surgical management of large ovarian tumors: Case report and literature review. Journal of Obstetrics and Gynaecology Research, 46(2), 240–245. https://doi.org/10.1111/jog.14123

XV. Singh, P., & Kumar, A. (2018). Challenges in diagnosis and management of giant ovarian cysts in low-resource settings. International Journal of Surgery Case Reports, 48, 12–17.

https://doi.org/10.1016/j.ijscr.2018.04.019

Most read articles by the same author(s)